Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.
| Conditions: | Cancer |
| Start Date: | October 1, 2009 |
| Phase: | Phase II |
| Status: | Recruiting |
| NCT ID: | NCT00996567 |
| Study Type: | Interventional |
| Intervention: | Drug: Cetuximab (Erbitux) |
| Study Design: | Allocation: Non-Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | University Hospital, Ghent|Merck |
| Ages: | Adult|Senior |
| Enrollment: | 18 |
| Funded By: | Other|Industry |
| First Received: | October 15, 2009 |
| End Date: | September 1, 2012 |
| Last Updated: | October 15, 2010 |
| Last Verified: | October 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
